| False-positive and false-negative COVID-19 cases: respiratory prevention and management strategies, vaccination, and further perspectives DS Mouliou, KI Gourgoulianis Expert review of respiratory medicine 15 (8), 993-1002, 2021 | 126 | 2021 |
| Current evidence in SARS-CoV-2 mRNA vaccines and post-vaccination adverse reports: knowns and unknowns DS Mouliou, E Dardiotis Diagnostics 12 (7), 1555, 2022 | 36 | 2022 |
| Estimates of COVID-19 risk factors among social strata and predictors for a vulnerability to the infection DS Mouliou, OS Kotsiou, KI Gourgoulianis International Journal of Environmental Research and Public Health 18 (16), 8701, 2021 | 32 | 2021 |
| COVID-19 smart diagnosis in the emergency department: all-in in practice DS Mouliou, I Pantazopoulos, KI Gourgoulianis Expert Review of Respiratory Medicine 16 (3), 263-272, 2022 | 25 | 2022 |
| COVID-19 ‘asymptomatic’patients: an old wives’ tale DS Mouliou, KI Gourgoulianis Expert Review of Respiratory Medicine 16 (4), 399-407, 2022 | 23 | 2022 |
| Social response to the vaccine against COVID-19: the underrated power of influence DS Mouliou, I Pantazopoulos, KI Gourgoulianis Journal of Personalized Medicine 12 (1), 15, 2021 | 20 | 2021 |
| Societal criticism towards COVID-19: assessing the theory of self-diagnosis contrasted to medical diagnosis DS Mouliou, I Pantazopoulos, KI Gourgoulianis Diagnostics 11 (10), 1777, 2021 | 19 | 2021 |
| Repeated antigen-based rapid diagnostic testing for estimating the coronavirus disease 2019 prevalence from the perspective of the workers’ vulnerability before and during the … OS Kotsiou, I Pantazopoulos, D Papagiannis, EC Fradelos, ... International Journal of Environmental Research and Public Health 18 (4), 1638, 2021 | 19 | 2021 |
| COVID-19 diagnosis in the emergency department: seeing the tree but losing the forest DS Mouliou, I Pantazopoulos, K Gourgoulianis Emergency Medicine Journal 39 (7), 563-563, 2022 | 13 | 2022 |
| Medical/surgical, cloth and FFP/(K) N95 masks: unmasking preference, SARS-CoV-2 transmissibility and respiratory side effects DS Mouliou, I Pantazopoulos, KI Gourgoulianis Journal of Personalized Medicine 12 (3), 325, 2022 | 13 | 2022 |
| C-reactive protein: pathophysiology, diagnosis, false test results and a novel diagnostic algorithm for clinicians DS Mouliou Diseases 11 (4), 132, 2023 | 12 | 2023 |
| Managing viral emerging infectious diseases via current molecular diagnostics in the emergency department: the tricky cases DS Mouliou Expert Review of Anti-infective Therapy 20 (9), 1163-1169, 2022 | 9 | 2022 |
| Analysis of ADORA2A rs5760423 and CYP1A2 rs762551 genetic variants in patients with Alzheimer’s disease V Siokas, DS Mouliou, I Liampas, AM Aloizou, V Folia, E Zoupa, ... International Journal of Molecular Sciences 23 (22), 14400, 2022 | 7 | 2022 |
| The deceptive COVID-19: lessons from common molecular diagnostics and a novel plan for the prevention of the next pandemic DS Mouliou Diseases 11 (1), 20, 2023 | 6 | 2023 |
| Temelimab for MS and SARS-CoV-2: Could it be a double-edged blessing? DS Mouliou, E Dardiotis Multiple Sclerosis and Related Disorders 64, 2022 | 6 | 2022 |
| John Cunningham Virus and Progressive Multifocal Leukoencephalopathy: A Falsely Played Diagnosis DS Mouliou Diseases 12 (5), 100, 2024 | | 2024 |
